CBIH Cannabis Bioscience International Holdings, Inc.
Fundamentals / CIK 0001411057 / USDCannabis Bioscience International Holdings, Inc. reported $124K in revenue and a net loss of $515K for the trailing twelve months ended February 28, 2026 (down 25.0% year over year), with a 78.8% gross margin and a -322.6% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CBIH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$124K -25.0% YoY
-
Operating Income TTM-$399K -322.6% margin
-
Net Income TTM-$515K -416.8% net margin
-
Diluted EPS TTM$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Feb 28, 2026-- Total debt: $264K
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | May 31 | May 31 | May 31 |
|---|---|---|---|
| Revenue | $303K | $249K | $317K |
| Cost of Revenue | $40K | $46K | $93K |
| Gross Profit | $263K | $203K | $223K |
| Total Operating Expenses | $684K | $689K | $1.21M |
| Operating Income | -$421K | -$486K | -$983K |
| Interest Expense | $136K | $154K | $91K |
| Income Tax Expense | -- | $0 | $0 |
| Net Income | -$549K | -$651K | -$1.03M |
| Basic EPS | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 |
| Basic Shares Outstanding | 10.72B | 10.32B | 9.00B |
| Diluted Shares Outstanding | 10.72B | 10.32B | 9.00B |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11K | $53K | $24K | $35K | $15K | $74K | $179K | $76K |
| Cost of Revenue | $3.0K | $10K | $8.1K | $4.5K | $19K | $7.8K | $8.4K | $9.9K |
| Gross Profit | $8.2K | $43K | $16K | $30K | -$4.5K | $66K | $171K | $66K |
| Total Operating Expenses | $101K | $139K | $91K | $165K | $125K | $126K | $268K | $96K |
| Operating Income | -$93K | -$96K | -$75K | -$135K | -$129K | -$60K | -$98K | -$30K |
| Interest Expense | $11K | $18K | $17K | $103K | $22K | $8.7K | $2.3K | -- |
| Net Income | -$104K | -$117K | -$83K | -$212K | -$181K | -$80K | -$76K | -$136K |
| Basic EPS | -$0.00 | -$0.00 | -$0.00 | -- | -$0.00 | -$0.00 | -$0.00 | -- |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -- | -$0.00 | -$0.00 | -$0.00 | -- |
| Basic Shares Outstanding | 11.63B | 11.63B | 11.63B | -- | 10.73B | 10.50B | 10.46B | -- |
| Diluted Shares Outstanding | 11.63B | 11.63B | 11.63B | -- | 10.73B | 10.50B | 10.46B | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | May 31 | May 31 | May 31 |
|---|---|---|---|
| Accounts Receivable, Net | $6.4K | $20K | $10.0K |
| Other Current Assets | $598 | $598 | $598 |
| Total Current Assets | $29K | $21K | $19K |
| Total Non-Current Assets | $2.8K | $36K | $24K |
| Total Assets | $32K | $57K | $43K |
| Short-Term Debt | $15K | $7.1K | $15K |
| Deferred Revenue (Current) | -- | $0 | $29K |
| Total Current Liabilities | $946K | $882K | $386K |
| Long-Term Debt | $250K | $249K | $250K |
| Total Non-Current Liabilities | $250K | $254K | $250K |
| Total Liabilities | $1.20M | $1.14M | $635K |
| Total Debt (incl. Leases) | $269K | $283K | $269K |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$5.88M | -$5.33M | -$4.68M |
| Total Stockholders' Equity | -$1.16M | -$1.08M | -$592K |
| Total Equity | -$1.16M | -$1.08M | -$592K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 |
|---|---|---|---|---|---|---|---|---|
| Accounts Receivable, Net | $1.3K | $22K | $9.0K | $6.4K | $17K | $20K | $17K | $19K |
| Other Current Assets | $188 | $188 | $598 | $598 | $598 | $598 | $598 | -- |
| Total Current Assets | $1.5K | $22K | $19K | $29K | $19K | $21K | $18K | $20K |
| Total Non-Current Assets | $0 | $0 | $0 | $2.8K | $28K | $36K | $76K | $82K |
| Total Assets | $1.5K | $22K | $19K | $32K | $46K | $57K | $94K | $102K |
| Short-Term Debt | $15K | $15K | $15K | $15K | $7.1K | $7.1K | $7.1K | $12K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| Total Current Liabilities | $1.22M | $1.14M | $1.02M | $946K | $852K | $882K | $801K | $660K |
| Long-Term Debt | $250K | $250K | $250K | $250K | $250K | $249K | $250K | $250K |
| Total Non-Current Liabilities | $250K | $250K | $250K | $250K | $250K | $254K | $269K | $283K |
| Total Liabilities | $1.47M | $1.39M | $1.27M | $1.20M | $1.10M | $1.14M | $1.07M | $944K |
| Total Debt (incl. Leases) | $264K | $264K | $264K | $269K | $279K | $283K | $332K | $266K |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$6.19M | -$6.08M | -$5.97M | -$5.88M | -$5.41M | -$5.33M | -$5.20M | -$5.20M |
| Total Stockholders' Equity | -$1.47M | -$1.36M | -$1.25M | -$1.16M | -$1.06M | -$1.08M | -$976K | -$842K |
| Total Equity | -$1.47M | -$1.36M | -$1.25M | -$1.16M | -$1.06M | -$1.08M | -$976K | -$842K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | May 31 | May 31 | May 31 |
|---|---|---|---|
| Net Income | -$549K | -$651K | -$1.03M |
| Stock-Based Compensation | -- | $0 | $12K |
| Change in Receivables | $14K | -$10K | -$4.9K |
| Operating Cash Flow | -$330K | -$479K | -$898K |
| Common Stock Issued | $244K | $70K | $802K |
| Financing Cash Flow | $342K | $471K | $875K |
| Net Change in Cash | $12K | -$8.2K | -$23K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$104K | -$117K | -$83K | -$212K | -$181K | -$80K | -$76K | -$136K |
| Change in Receivables | $21K | -$13K | -$2.6K | -$3.7K | $11K | $3.4K | $3.0K | -$3.1K |
| Operating Cash Flow | -$15K | -$5.5K | -$104K | -$144K | -$83K | -$72K | -$30K | -$174K |
| Common Stock Issued | -- | -- | $0 | -- | -- | -- | $0 | -$5.0K |
| Financing Cash Flow | -- | -- | -- | $157K | -- | -- | $31K | $174K |
| Net Change in Cash | -$42 | -$91 | -$13K | $12K | -$454 | $33 | $214 | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | May 31 | May 31 | May 31 |
|---|---|---|---|
| Gross Margin | 86.8% | 81.7% | 70.5% |
| Operating Margin | -139.1% | -195.4% | -310.4% |
| Net Profit Margin | -181.1% | -261.8% | -325.9% |
| Return on Assets (ROA) | -1721.5% | -1139.5% | -2380.2% |
| Current Ratio | 0.03x | 0.02x | 0.05x |
| Revenue Growth (YoY) | +21.8% | -21.5% | -- |
| Gross Profit Growth (YoY) | +29.4% | -9.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.8% | 66.6% | 73.1% | 86.8% | 86.8% | 89.6% | 87.3% | 81.7% |
| Operating Margin | -322.6% | -341.4% | -268.7% | -139.1% | -91.9% | -94.9% | -107.6% | -185.2% |
| Net Profit Margin | -416.8% | -465.3% | -374.3% | -181.1% | -137.5% | -137.1% | -153.8% | -261.7% |
| Return on Assets (ROA) | -33373.6% | -2677.7% | -2930.8% | -1721.5% | -- | -- | -1179.5% | -1139.5% |
| Current Ratio | 0.00x | 0.02x | 0.02x | 0.03x | -- | -- | 0.02x | 0.02x |
| Revenue Growth (YoY) | -25.0% | -28.3% | -86.5% | -53.9% | -59.0% | +16.5% | +145.7% | -- |
| Gross Profit Growth (YoY) | -- | -35.6% | -90.6% | -53.9% | -118.1% | +36.6% | +166.4% | -- |